Antiparkinsonian ọgwụ "Madopar": ntuziaka maka ojiji

Medicine "Madopar" ntụziaka ntuziaka na-akọwa dị ka a jikọtara n'aka maka n'imeso Parkinson oria. Ịnata a ọgwụ irè eliminates muscle rigidity, hypokinesia na dysphagia. Ke adianade do, ọgwụ ọjọọ, "Madopar" ngwa ngwa ịnagide salivation na ịma jijiji. The akpọ mmetụta nke eji ihe mgbochi-Parkinson ọgwụ na-eme ememe mgbe isii ka ụbọchị asatọ mgbe o mmalite nke n'ikuku, na nke kacha mma na-arụpụta - na iri-na-ise na orú ubọchi na iri. Ọ bụ karịsịa uru arịba ama na nkà mmụta ọgwụ na-ọma-akpali esi kpọpụ mmadụ nile nke afo ọdịnaya, nke n'ikpeazụ oji kacha plasma ịta mgbe naanị awa atọ.

Emepụta jikọtara pụtara "Madopar" (ntụziaka ntuziaka na-bụchaghị gụnyere) n'ụdị mbadamba, capsules na dragees ntabi. Nke ikpeazụ nwere a siri ike Ọdịdị na gelatin-acha anụnụ anụnụ pink ụlọ.

The mejupụtara nke ọ bụla Capsule nwere Levodopa na benserazide eme ka ifịk ifịk mmiri. "Madopar" mkpụrụ ọgwụ Valium mkpụrụ ọgwụ na-acha ọbara ọbara na agba ya na ala isi. Na ha mejupụtara na-agụnye bekee ndị dị otú ahụ dị ka levodopa na benserazide.

Nye iwu ka a gụkọta nkwadebe "Madopar" ntụziaka ntuziaka na-adụ ọdụ bụ isi na-emeso ndị mmadụ na-ata ahụhụ si na ọrịa Parkinson. Ke adianade do, na ngwá ọrụ na-kenyere mgbe iji kpochapụ -erughị ala ụkwụ syndrome. N'ikpeazụ, iji nke a na nkà mmụta ọgwụ na-atụ aro ka ndị mmadụ na-akụrụ odida.

Dị ka ndị isi contraindications, mgbe ahụ, nye iwu mbadamba na capsules "Madopar 'ntuziaka maka ojiji na-nditịm ajuru aju ka ndị ọrịa ndị chọtara a oké njọ ọrịa obi, ọrịa n'akuku-mmechi glaucoma ma ọ bụ ọrịa uche. Ke adianade do, ndị dọkịta nwere ike ikwu bụghị iji ifịk antiparkinsonian ọgwụ bụrụ nhata na decompensated imeju, akụrụ, ma ọ bụ endocrine usoro. Ọ na-machibidoro nye iwu a ọgwụ ka ndị mmadụ n'okpuru afọ iri abụọ na ise.

Ọ bụrụ na onye ọrịa nwere adịghị anabata levodopa ma ọ bụ benserazide, n'otu aka ahụ, ga-amalite na-ewere ọgwụ "Madopar." Nyocha, nakwa dị ka ntụziaka, ikwu banyere undesirability nke ebe nke jikọtara ọgwụ maka ndị na-arịa ụkwara ume ọkụ. Na oke-elekọta ẹka antiparkinsonian mkpa ọrịa na-arụsi ọrụ ike peptic ọnyá afọ. Iji ọgwụ ọjọọ, "Madopar" ekwesịghị ịbụ na ihe banyere akpọ mgbochi nke ụmị ọkpụkpụ hematopoiesis, melanoma, afọ ime, ma ọ bụ osteomalacia. Lactation oge, arrhythmia na myocardial infarction na-gụnyere ke ndepụta nke kpọmkwem contraindications.

Ke adianade niile nke n'elu, ọ ga-kwuru banyere omume mmetụta na oghom Jeremaya mere na ike ga-triggered site na-ewere mkpụrụ ọgwụ "Madopar." Ka ihe atụ, n'ụbọchị ndị mbụ nke ọgwụgwọ mgbe ụfọdụ akara ọnụ ke agụụ, epigastric mgbu, dysphagia na vomiting. E nwekwara a obere ihe ize ndụ nke orthostatic hypotension, thrombocytopenia, leukopenia, hemolytic anaemia, ma ọ bụ tachycardia. Ke adianade do, ụfọdụ ọrịa mkpesa nke ịda mbà n'obi, ihi ụra, ehighi ura, ntachi na ibu ibu.